Curis Lifesciences Limited IPO
Curis Lifesciences is a pharmaceutical manufacturer engaged in producing a diverse range of formulations, including tablets, capsules, oral liquids, external preparations, and sterile ophthalmic ointments. The company operates across domestic and global markets under three business verticals — Loan License Manufacturing, Contract Manufacturing, and Direct Export/Own Brand Marketing. In loan license manufacturing, it undertakes production on behalf of clients who supply raw materials and formulations. Under contract manufacturing, Curis manages procurement and production, while clients handle branding and marketing. In direct exports, the company markets its own brands in Yemen and Kenya, handling end-to-end operations independently.
Price Band₹120 - ₹128 |
Dates07 Nov - 11 Nov |
GMP₹8 (6.25%) |
Subscriptions74.52 times |
Issue Size₹27.52 Crs |
Curis Lifescience IPO Key Dates
Opening Date
07 Nov 25
Closing Date
11 Nov 25
Basis Of Allotment
12 Nov 25
Initiations Of Refund
13 Nov 25
Credit Of Shares
13 Nov 25
Listing Date
13 Nov 25
Curis Lifescience IPO Objects
- Capital Expenditure towards Upgradation/Improvement of the existing Manufacturing Facilities.
- Capital Expenditure towards Construction of a Storage Facility
- Pre-payment/Repayment of outstanding Secured Loans
- Product Registrations in other countries
- Funding the Working Capital Requirements & General Corporate Purposes
- General Corporate Purposes
Curis Lifescience IPO Details
Price Band₹120 - ₹128 |
Listing AtNSE SME |
IPO Issue Type100% Book Built Offer |
Fresh Issue₹27.52 Cr (0.22 Cr Shares) |
Offer For Sale₹0.00 (0.00 Shares) |
Total Issue₹27.52 Cr (0.22 Cr Shares) |
Face Value₹10 per equity share |
Curis Lifescience IPO Lot Information
| Investor Category | Lot | Shares | Amount | |
|---|---|---|---|---|
| Individual Investor |
Minimum
2
2,000
2,56,000
Maximum
2
2,000
2,56,000
|
|||
| Small HNI |
Minimum
3
3,000
3,84,000
Maximum
7
7,000
8,96,000
|
|||
| Big HNI |
Minimum
8
8,000
10,24,000
|
|||
Curis Lifescience IPO Subscription
Updated as on 11-Nov-2025 19:00:50 hrs
| Investor Category | Subscription (times) | Shares Offered | Shared Bid |
|---|---|---|---|
| QIB | 96.41 | 4,08,000 | 3,93,35,000 |
| NII | 115.81 | 3,08,000 | 3,56,71,000 |
| bNII | 143.73 | 2,05,333 | 2,95,12,000 |
| sNII | 59.99 | 1,02,667 | 61,59,000 |
| Individual Investor | 44.28 | 7,16,000 | 3,17,06,000 |
| Total | 74.52 | 14,32,000 | 10,67,12,000 |
Curis Lifescience IPO GMP
The estimated Grey Market Premium of Curis Lifescience IPO is ₹8 per share (6.25%)
Category Allocation
| Particulars | Allocation |
|---|---|
| QIB | Not more than 50% of Net Offer |
| NII | Not less than15 % of Net Offer |
| Retail | Not less than35 % of Net Offer |
| Market Maker | 108000 Eq. Share |
Curis Lifescience IPO Financials
| Particulars | Jul-25 | Mar-25 | Mar-24 | Mar-23 |
|---|---|---|---|---|
| Revenue from Operations | 19.50 | 49.13 | 35.56 | 35.45 |
| Profit after Tax | 2.87 | 6.11 | 4.87 | 1.88 |
| Net Worth | 19.10 | 16.23 | 5.87 | 1.01 |
| Total Borrowing | 15.32 | 15.62 | 17.09 | 16.19 |
| Total Assets | 56.29 | 42.53 | 33.88 | 29.75 |
| NAV per share (in ₹) | 32.18 | 27.34 | 117.46 | 20.12 |
| EPS - Basic (in ₹) | 4.84 | 10.29 | 8.26 | 3.18 |
The financial information presented is on a consolidated basis
Key Performance Indicators
| KPI | Values |
|---|---|
| EBITDA | 19.41% |
| PAT | 12.43% |
| ROE | 55.25% |
| ROCE | 27.83% |
| Debt to Equity | 0.96 |
| PE Ratio | 12.44 |
| PB Ratio | 4.68 |
| Mkt Cap (in Crs.) | 103.48 |
- All Ratios are based on Mar 2024-25.
- PE, PB, and Post-Issue Market Capitalization are calculated based on the upper price band.
Curis Lifescience IPO Peer Comparision
| Particulars | Curis Lifesciences | Sotac Pharma | PeeLincoln Pharma |
|---|---|---|---|
| Revenue from Ops (in Crs.) | 49.13 | 62.38 | 623.23 |
| PAT (In Crs.) | 6.11 | 4.77 | 82.35 |
| EPS - Basic | 10.29 | 4.32 | 41.11 |
| NAV per share | 27.34 | 47.99 | 335.34 |
| RONW | 37.62% | 9.00% | 12.27% |
| EBITDA | 19.41% | 12.31% | 16.29% |
| PAT Margin | 12.43% | 7.65% | 13.21% |
| Price to earning (PE) | 12.44 | 18.30 | 12.21 |
| Debt to Equity | 0.96 | 0.38 | - |
- All the information pertains to FY 2024-25
- The PE ratio is calculated using the Upper Price Band for the Issuer and the closing price as of October 28, 2025 for Peers
Curis Lifescience IPO Peer Comparision
| Particulars | Curis Lifesciences |
|---|---|
| Revenue from Ops (in Crs.) | 49.13 |
| PAT (In Crs.) | 6.11 |
| EPS - Basic | 10.29 |
| NAV per share | 27.34 |
| RONW | 37.62% |
| EBITDA | 19.41% |
| PAT Margin | 12.43% |
| Price to earning (PE) | 12.44 |
| Debt to Equity | 0.96 |
| Sotac Pharma | PeeLincoln Pharma |
|---|---|
| 62.38 | 623.23 |
| 4.77 | 82.35 |
| 4.32 | 41.11 |
| 47.99 | 335.34 |
| 9.00% | 12.27% |
| 12.31% | 16.29% |
| 7.65% | 13.21% |
| 18.30 | 12.21 |
| 0.38 | - |
- All the information pertains to FY 2024-25
- The PE ratio is calculated using the Upper Price Band for the Issuer and the closing price as of October 28, 2025 for Peers
Promoter Details
| Name | Shareholding |
|---|---|
| Piyush Antala | 21.32% |
| Siddhant Pawasia | 25.95% |
| Jaimik Mansukhlal Patel | 14.83% |
| Dharmesh Patel | 18.07% |
| Others | 12.51% |
| Total | 92.68% |
Management Details
| Name | Designation |
|---|---|
| Dharmesh Patel | Chairman & MD |
| Pragnesh Sharma | CFO |
Company Details
Name: Curis Lifesciences Limited
Address: PF-23, GIDC Sanand - II, Industrial Estate, Ahmedabad, Sanand, Gujarat-382110, India
Number: +91 99045 22543
Email: cs@curisls.com
Website: https://curisls.com/
Book Running Lead Managers (BRLMs)
RTAs
MUFG Intime India
Visit WebsiteFrequently Asked questions?
Find answers to common questions that come in your mind related to IPO.
Curis Lifescience IPO is a SME IPO having an issue size of Rs. ₹27.52 Crs. Curis Lifescience IPO is priced at ₹120 - ₹128 per share. The issue opens on 07 Nov 25 and closes on 11 Nov 25.
Curis Lifescience IPO opens on 07 Nov 25 and closes on 11 Nov 25.
The estimated Grey Market Premium of Curis Lifescience IPO is ₹8 per share (6.25%).
The minimum lot size of Curis Lifescience IPO is 1000 shares & the minimum application amount is Rs. 128000.
The allotment date of Curis Lifescience IPO is 12 Nov 25.
The listing date of Curis Lifescience IPO is 13 Nov 25.
Curis Lifescience IPO is subscribed 74.52 times.
Curis Lifescience IPO is priced at ₹120 - ₹128 per share.
Click the allotment link on Curis Lifescience IPO page of IPO360.
- Go to Kite App → Tap on Bids → Tap on IPO
- Select the IPO → Tap on apply → Enter UPI ID
- Enter Qty and Price
- Submit the application
- Approve the UPI Mandate on your UPI app
- Go to Groww App → Stocks Section → Select IPO option
- Select the IPO you want to apply
- Enter your bid details and price
- Enter UPI ID & submit
- Approve the UPI Mandate on your UPI app
- Log in to your bank's net banking portal.
- Navigate to the 'IPO' or 'ASBA' section.
- Select Curis Lifescience IPO from the list of available IPOs.
- Enter the required details: Bid quantity, Price, DP ID & Client ID, etc
- Submit the application.
- Money will remain blocked till the refund date
